28/11/05
Stallergènes: the positive results of the grass pollen tablet study allow the active continuation of its development program.
The VO 34 study of rhino-conjunctivitis allergies to grass pollen (« hay fever») enables to conclude that the allergen tablet ORALAIR® Grasses induces, right from the first season of treatment, a 37% reduction(*) of symptoms and...
13/10/05
17% increase in 2005 3rd quarter Group sales
(€ millions)20052004% growth3rd quarter22.7619.42+17France & overseas territories10.839.33+16Subsidiaries (1)8.887.42+20Distributors3.052.67+14 9 months 78.89 65.63 +20France & overseas...
07/08/07
2005 1st Half-Year Group Sales Up 21%
(€millions)2004(3) 2005% changeQ2 sales21.1025.8322%France *10.7613.0721%Subsidiaries **7.369.9135%Distributors ***2.982.85(4%)1st half-year sales46.2056.1221%France *24.7530.7824%Subsidiaries **15.8919.5623%Distributors...
14/09/05
Excellent half year performance,Operating profit up 39%,Net profit up 58%
The Board of Directors, meeting on 13 September 2005, under the chairmanship of Albert SAPORTA approved the consolidated financial statements at 30 June 2005, prepared in accordance with the new accounting standards. the...
14/04/05
Significant increase in 2005 1st quarter sales: + 21%
€ millions 2005 Q 1 2004 Q1 % growth France 17.70 13.99 + 27% Subsidiaries (1) 9.66 8.54 + 13% Distributors 2.94 2.58 + 14% Total 30.30 25.11 + 21%
(1) Germany, Belgium, Italy, Spain and Portugal Stallergènes...
01/04/05
Project to buy back shares
Stallergènes announces its intention to implement shortly the share buyback programme adopted at its General Meeting of December 20, 2004. This should take the form of an Offre Publique d’Achat Simplifiée (Simplified Public...
17/03/05
2004 Financial Year Results,Strong growth in profitability enabling an acceleration in R&D efforts,Strengthening of commercial positions in Spain and Portuga
The Board of Directors, meeting on 15 March 2005 under the chairmanship of Albert Saporta, approved the 2004 consolidated financial statements of Stallergenes Group.
(€ millions) 2003 % of sales 2004 ...
